Investor Presentation
Interim Results
6 months to December 2022
Keith Broadbent
Chief Executive Officer
Mark Chapman
Chief Financial Officer
March 2023
Period Highlights
- Group Revenues increased by 50% to £1.78 million (H1 FY22 £1.19 million)
- Sales of biomedical inks achieved in Europe and advanced trials being conducted which include electronic blood glucose reader compatibility tests
- One tonne of functionalised powder supplied to leading cycle tyre manufacturer Vittoria Spa - more orders anticipated in the current period.
- Developed a prototype underfloor heating solution - potential to replace high voltage electric or water-basedfloor heating systems in residential buildings.
- As expected, strong growth in US revenues with rebound in Silicon Carbide powder sales and growing blanks and finished tools sales.
2
Haydale - Our USP
- Haydale has solved the Graphene Challenge
- A potentially inert substance made usable through functionalisation
- Patented HDPlas™ functionalisation process
- Greener, cleaner and more tunable 'powder in - powder out'
- Patent protected in key countries, significant in house 'know how'
- Right time to focus on Graphene and other nanomaterials
- Fourth industrial revolution - market forecast to grow exponentially - Global nanomaterials market currently worth US$9.68 billion1.
- Consistent process that supports industrial scale
- Consistency is our key to meeting customers quality requirements
- Capacity to produce on an industrial scale
- Installed production capacity sufficient for breakeven and beyond
- Further Scale up can be achieved with a RoI of less than 12 months
1. Precedence Research - 'Nanomaterials Market Size, Growth, Trends - Report 2022-2030
Our Priorities
Secure | Optimise | ||
short to | |||
capacity to | |||
medium | |||
meet | |||
term | |||
volume | |||
commercial | |||
demands | |||
revenue | |||
Upgrade | |||
operational | Extend our | ||
capability | |||
technology | |||
- satisfy | |||
advantage | |||
large | |||
customers | |||
Provide a | Create | ||
significant | options at | ||
return to | our US | ||
investors | operation |
Within this framework, the company is focusing on 5 key products
- Biomedical Inks
- Heating Products
- Security Inks
- Elastomers (Tyres/shoes)
- Paints and Coatings
assessed to provide short to medium term profit and cashflow opportunities.
4
Key Product Update
Key Benefit | Status |
Target Customer
Update
Biomedical lInks | ||
Security Inks | Conductive/ | |
Shoes/ Tyres | Elastomers | |
Customers | Nano Material | |
Cost effective, non-invasive monitoring of chronic conditions and detecting other diseases
Cost effective and environmentally friendlier solution to reduce metallic content of security tags
Improved rubber compounds - increased tear strength, improved slip resistance and weight reduction
Functionalising customers nanomaterials to improve performance
Advanced testing with a number of customers in Europe and East Asia
Commercial Project with leading supplier of RFID solutions in progress
One tonne delivered to Vittoria. Further orders to follow.
Several large suppliers engaged to enhance the performance of their raw material offering
Major Market - Glucose monitoring companies - potential for other diseases
Project Sponsor
Vittoria
Other tyre companies
Footwear companies
Graphene suppliers
Boron Nitride suppliers
Ink now developed. First sales achieved, challenges to commercialization being overcome
Project on plan
First volume sales delivered, focussing on further customer penetration
Developing revenue stream.
5
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Haydale Graphene Industries plc published this content on 03 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 April 2023 17:05:03 UTC.